ASO visual abstract: RAS mutation status should not be used to predict outcome from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases
| dc.contributor.author | Bhullar, Dilraj | |
| dc.contributor.author | O'Dwyer, Sarah T | |
| dc.contributor.author | Wilson, Malcolm S | |
| dc.contributor.author | Saunders, Mark P | |
| dc.contributor.author | Kochhar, Rohit | |
| dc.contributor.author | Barriuso, Jorge | |
| dc.contributor.author | Aziz, Omer | |
| dc.date.accessioned | 2023-01-16T14:12:45Z | |
| dc.date.available | 2023-01-16T14:12:45Z | |
| dc.date.issued | 2022 | en |
| dc.identifier.citation | Bhullar D, O'Dwyer S, Wilson M, Saunders MP, Kochhar R, Barriuso J, et al. ASO Visual Abstract: RAS Mutation Status Should not be Used to Predict Outcome from Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases. Ann Surg Oncol. 2022 Nov 20. PubMed PMID: 36404378. Epub 2022/11/21. eng. | en |
| dc.identifier.pmid | 36404378 | en |
| dc.identifier.doi | 10.1245/s10434-022-12780-x | en |
| dc.identifier.uri | http://hdl.handle.net/10541/625863 | |
| dc.description.abstract | None | en |
| dc.language.iso | en | en |
| dc.relation.url | https://dx.doi.org/10.1245/s10434-022-12780-x | en |
| dc.title | ASO visual abstract: RAS mutation status should not be used to predict outcome from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases | en |
| dc.type | Article | en |
| dc.contributor.department | Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK | en |
| dc.identifier.journal | Annals of Surgical Oncology | en |
| dc.description.note | en] |